David Ruiz-Carillo

Title: The Innovative Contributions of David Ruiz-Carillo

Introduction

David Ruiz-Carillo is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biochemistry, particularly in the study of glutaminyl cyclase and isoglutaminyl cyclase. With a total of 3 patents to his name, his work has implications for understanding and potentially treating various health conditions.

Latest Patents

David's latest patents include the "Crystal structure of glutaminyl cyclase," which details novel crystal structures of human and murine glutaminyl cyclase (QC, EC 2.3.2.5). This patent outlines methods for preparing the crystals and their use in identifying inhibitors of both human and murine glutaminyl cyclase. Another significant patent is the "Crystal structure of isoglutaminyl cyclase," which describes a crystal comprising human isoglutaminyl cyclase characterized by a space group of P1211 and specific unit cell dimensions.

Career Highlights

David Ruiz-Carillo is currently employed at Probiodrug AG, where he continues to advance his research in enzymatic structures. His work is pivotal in the ongoing exploration of therapeutic targets in the field of biochemistry.

Collaborations

David collaborates with esteemed colleagues such as Stephan Schilling and Jens-Ulrich Rahfeld, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

David Ruiz-Carillo's contributions to the field of biochemistry through his patents and collaborative efforts highlight his role as an influential inventor. His work not only advances scientific knowledge but also opens new avenues for potential therapeutic applications.